Viewing Study NCT03732235


Ignite Creation Date: 2025-12-24 @ 10:34 PM
Ignite Modification Date: 2026-02-19 @ 9:01 AM
Study NCT ID: NCT03732235
Status: UNKNOWN
Last Update Posted: 2019-02-21
First Post: 2018-10-30
Is Gene Therapy: True
Has Adverse Events: False

Brief Title: TACE Associated to Systemic Bevacizumab for the Treatment of Refractory Liver Metastases From Colorectal Cancer
Sponsor: Giammaria Fiorentini
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Liver Metastasis Colon Cancer View
Keywords:

Keywords

Keyword Brief Keyword Text View
None Liver Metastases View
None Transarterial chemoembolization View
None Bevacizumab View
None Anti-angiogenesis View
None Irinotecan View
None Embolics View
None FOLFIRI View